Table 2.
Expression of ganglioside GM2 in mesothelioma patient samples
| Patient ID | Staining frequency, % | Staining intensity | Tissue type | Age, years | Sex | Stage |
|---|---|---|---|---|---|---|
| #1 | 0 | 0 | Biphasic | 58 | M | II |
| #2 | 30 | 2 | Biphasic | 69 | M | I |
| #3 | 0 | 0 | Meso | 53 | M | IV |
| #4 | 0 | 0 | Meso | 57 | F | III |
| #5 | 30 | 3 | Meso | 73 | M | NR |
| #6 | 0 | 0 | Biphasic | 52 | M | III |
| #7 | 0 | 0 | Biphasic | 71 | M | IV |
| #8 | 80 | 2 | Biphasic | 50 | M | IV |
| #9 | 30 | 1 | Meso | 65 | M | III |
| #10 | 0 | 0 | Meso | 71 | M | IIA |
| #11 | 0 | 0 | Desmoplastic | 81 | M | NR |
| #12 | 50 | 3 | Meso | 66 | M | II |
| #13 | 0 | 0 | Meso | 86 | M | NR |
| #14 | 100 | 2 | Desmoplastic | 55 | M | I |
| #15 | 0 | 0 | Desmoplastic | 63 | NR | I |
| #16 | 90 | 1 | Epithelial | 61 | M | IV |
| #17 | 10 | 1 | Meso | 68 | M | III |
| #18 | 40 | 3 | Biphasic | 62 | M | III |
| #19 | 80 | 3 | Desmoplastic | 57 | M | NR |
| #20 | 100 | 3 | Meso | 69 | M | II |
| #21 | 100 | 1 | Biphasic + desmoplastic | 68 | M | III |
| #22 | 100 | 3 | NR | 65 | M | NR |
| #23 | 50 | 3 | Meso | 69 | M | II |
| #24 | 20 | 2 | Meso | 57 | F | III |
| #25 | 0 | 0 | Biphasic | 50 | M | IV |
| #26 | 0 | 0 | Epithelial | 81 | M | NR |
Criteria for staining intensity: 0, negative; 1, faint; 2, moderate; 3, strong. F, female; M, male; Meso, unclassified mesothelioma; NR, not reported.